Previous 10 | Next 10 |
Adamis Pharmaceuticals (ADMP) +66% as its epinephrine products added to Walgreens club.Climate Change Crisis Real Impact I Acquisition Corporation (CLII) +48% as EV fast charging company EVgo to go public via SPAC.SCYNEXIS (SCYX) +36%.Humanigen (HGEN) +20% on expanding partners...
TAT Technologies (TATT) +37% after signing strategic agreement with Honeywell.Change Healthcare Inc. (CHNG) +35% as UnitedHealth to acquire the company for $25.75 in cash.DBV Technologies S.A. (DBVT) +19%.Aurora Cannabis (ACB) +17% on possible Georgia 'blue sweep'.HEXO (HEXO) +17%...
Cantor Fitzgerald analyst Louise Chen initiates coverage of Scynexis (SCYX) with an Overweight rating, citing peak sales potential of ibrexafungerp for the treatment of fungal infections is "underappreciated."The price target ((PT)) set to $30, implies a 313% increase from last price of $7.26...
Gainers: [[ISR]] +67.9%. [[CRNX]] +7.9%. [[SCPE]] +6.3%. [[SCYX]] +6.1%. [[ENSV]] +5.3%.Losers: [[MXC]] -11.5%. [[CLSD]] -10.0%. [[DWSN]] -9.9%. [[IRIX]] -8.9%. [[TITN]] -6.6%. For further details see: ISR, CRNX, MXC and CLSD among after-hours movers
Gainers: [[CLSD]] +9.9%. [[EBON]] +3.8%. [[ETM]] +3.6%. [[CVE]] +3.6%. [[UBX]] +3.6%.Losers: [[CGA]] -12.2%. [[CNF]] -12.1%. [[WBAI]] -10.7%. [[SCYX]] -9.2%. [[NRO]] -8.8%. For further details see: CLSD, EBON, CGA and CNF among after-hours movers
JERSEY CITY, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq: SCYX) today announced the closing of its previously announced underwritten public offering of common stock, pre-funded warrants and warrants. The shares and warrants were sold at a public offering price of $6.25 pe...
Gainers: MingZhu Logistics (YGMZ) +237%.Nxt-ID (NXTD) +99%.PainReform (PRFX) +39%.Takung Art (TKAT) +39%.Avenue Therapeutics (ATXI) +31%.Eloxx Pharmaceuticals (ELOX) +30%.Jupiter Wellness (JUPW) +29%.Vivos Therapeutics (VVOS) +25%.Cogent Biosciences (COGT) +24%.Marathon Patent ...
Gainers: Vivos Therapeutics (VVOS) +51%, Jupiter Wellness (JUPW) +21%, Evolus (EOLS) +27%, PainReform (PRFX) +24%, Rite Aid (RAD) +23%.Losers: BioCardia (BCDA) -23%, SCYNEXIS (SCYX) -19%, Zynerba Pharmaceuticals (ZYNE) -15%, Han...
SCYNEXIS ([[SCYX]] -17.9%) prices its previously announced public offering of common stock, pre-funded warrants and warrants, for gross proceeds of $85M.The shares and warrants are priced that $6.25/share and accompanying warrants, and the pre-funded warrants are being sold $6.249 per pre-fun...
JERSEY CITY, N.J., Dec. 17, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq:SCYX) today announced the pricing of its underwritten public offering of common stock, pre-funded warrants and warrants. The shares and warrants are being sold at a public offering price of $6.25 per share and accom...
News, Short Squeeze, Breakout and More Instantly...
JERSEY CITY, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that it will receive a $10 million development milestone payment un...